Company: PFSA
Filing Date: 2025-10-09
Form Type: S-1
Source: 0001213900-25-097860
Chunk: 11

Company: Profusa, Inc.
Filing Date: 2025-10-09
Form: S-1
Chunk 11
---
, can be found below, after this summary, and should be carefully considered, together with other information in this prospectus and our other filings with the SEC before making an investment decision in our securities. Risks Related to the Committed Equity Facility

| ● | It is not possible to predict the actual number of shares                                                                              
 of Common Stock, if any, we will sell under the Purchase Agreement to Ascent, or the actual gross proceeds resulting from those sales. |

| ● | The sale and issuance of our Common Stock to Ascent will                                                                               
 cause dilution to our existing stockholders, and the sale of Purchase Shares acquired by Ascent, or the perception that such sales may 
 occur, could cause the price of our Common Stock to fall.                                                                              |

| ● | Investors who buy Purchase Shares from Ascent at different 
 times will likely pay different prices.                    |

| ● | We may use the net proceeds from sales of shares of our Common                                                                           
 Stock made pursuant to the Purchase Agreement, if any, in ways with which you may not agree or in ways which may not yield a significant 
 return.                                                                                                                                  |

| ● | We will primarily use the net proceeds from this offering                                          
 to purchase Bitcoin, the price of which has been, and will likely continue to be, highly volatile. |

Risks Related to Our Business and Operations

| ● | We have substantial doubt about our ability to continue as a going concern, which may hinder our ability 
 to obtain further financing.                                                                             |

| ● | We have a limited operating history on which to assess the prospects for our business and we have incurred                        
 losses since inception. We anticipate that we will continue to incur significant losses for at least the next several years as we 
 continue to commercialize our existing products and services and seek to develop and commercialize new products and services.     |

| ● | We operate in a highly competitive market and face competition from large, well-established companies 
 with significant resources, and, as a result, we may not be able to compete effectively.              |

| ● | We are subject to a variety of risks due to our international operations that could adversely affect our 
 business, our operations or profitability and operating results.                                         |

| ● | There are a variety of oxygen monitoring and CGM products and technologies, and consumer confusion about                                  
 product features and technology could lead consumers to purchase competitive products instead of our products, or to conflate any adverse 
 events or safety issues associated with oxygen monitoring and CGM products with our products